跳转至内容
Merck
CN
  • Effects of oral hyposensitization therapy with nickel on haemoglobin and haematocrit values in sensitized patients.

Effects of oral hyposensitization therapy with nickel on haemoglobin and haematocrit values in sensitized patients.

International journal of immunopathology and pharmacology (2012-06-16)
A Tammaro, A Narcisi, P P Di Russo, C Abruzzese, C Caperchi, F Persechino, F R Parisella, S Persechino
摘要

Nickel deficiency leads to reduced iron content in organs and to reduced hemoglobin levels and haematocrit counts. We carried out a clinical trial of oral hyposensitization therapy with low doses of nickel on a group of 20 patients affected by systemic allergy to this sensitizer element and with a chronic relapsing low hemoglobin level and haematocrit count. We obtained interesting results on maintaining these values in treated patients.

材料
货号
品牌
产品描述

Sigma-Aldrich
硫酸镍(II) 六水合物, ACS reagent, ≥98%
Sigma-Aldrich
硫酸镍(II) 六水合物, ReagentPlus®, powder or crystals
Supelco
硫酸镍(II) 六水合物, ≥99.99% trace metals basis
Sigma-Aldrich
硫酸镍(II), anhydrous, 99.99% trace metals basis
Sigma-Aldrich
硫酸镍(II) 七水合物, purum p.a., crystallized, ≥99.0% (KT)
Sigma-Aldrich
硫酸镍(II) 七水合物, 99.999% trace metals basis
Sigma-Aldrich
硫酸镍(II)六水合物 七水合物, for nickel plating, DIN 50970 H, ≥20.6% Ni and Co basis